Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Lopez-Tarruella S, Guerrero-Zotano A, Antolin S, Cruz J, Martinez P, Rodriguez CA, Falo C, Rodriguez-Lescure A, Adrover E, Hernandez M, Andres R, Chacon JI, Alonso Romero JL, Miguel A, Gomez-Raposo C, Margeli M, Gonzalez I, Guerra JA, Anton A, Tibau A, Miralles JJ, Escudero MJ, Bezares S, Rojo F, Alvarez I. Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM). Ther Adv Med Oncol. 2026 Feb 20;18:17588359261421813. doi: 10.1177/17588359261421813. eCollection 2026. PubMed PMID: 41732657; PubMed Central PMCID: PMC12924966.
AÑO: 2026; IF: 4.2
Rosado-Jiménez L., Mestre-Terkemani Y., García-Aliaga Á., Sarabia-Meseguer M.D., Marín-Vera M., Macías-Cerrolaza J.A., Sánchez-Henarejos P., García-Hernández M.R., Zafra-Poves M., Álvarez-Abril B.C., López-Sánchez C.B., Moya-Martínez M.P., Pascual-Gilabert P., Cerón-Moreno A.M., Castillo-Guardiola V., Antón-Martínez D., Ayala-de la Peña F., Alonso-Romero J.L., Noguera-Velasco J.A., Ruiz-Espejo F. Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes. Familial Cancer. March 2026. 25. 10.1007/s10689-025-00521-4
AÑO: 2026; IF: 2.0
Encarnacion JA, Ibanez N, De la Fuente I, Ruiz P, Gonzalez S, Quiles B, Sanchez M, Bautista Y, Rodriguez C, Nadal JA, Marin M, Marin-Zafra G, Guirao M, Hernandez Q, Abrisqueta J, Abellan I, Montoya M, Ono A, Carbonell G, Frutos L, Ortiz E, Manso C, Royo-Villanova M, Alonso-Romero JL. Clinical Complete Response and Organ Preservation Strategies in Rectal Cancer: A Real-World Single-Center Experience Clinical Complete Response and Organ Preservation in Rectal Cancer. Cancers (Basel). 2026 Feb 27;18(5):763. doi: 10.3390/cancers18050763. PubMed PMID: 41827698; PubMed Central PMCID: PMC12985280.
AÑO: 2026; IF: 4.4
Almanchel-Rivadeneyra M, Alonso Romero JL, Tomas-Luiz A, Diaz Carrasco MS. Drug-drug interactions in adjuvant and neoadjuvant breast cancer therapy. Eur J Hosp Pharm. 2026 Jan 6:ejhpharm-2025-004761. doi: 10.1136/ejhpharm-2025-004761. Online ahead of print. PubMed PMID: 41494827.
AÑO: 2026; IF: 1.5
Mestre Terkemani Y, Rosado Jimenez L, Garcia Aliaga A, Sarabia Meseguer MD, Marin Vera M, Macias Cerrolaza JA, Sanchez Henarejos P, Garcia Hernandez MR, Zafra Poves M, Alvarez Abril B, Garcia Torralba E, Lopez Sanchez CB, Moya Martinez MP, Moreno Locubiche MA, Sanchez Martinez DA, Quiros Figello TA, Ceron Moreno AM, Exposito Garcia M, Anton Martinez D, Martinez Barba E, Ayala de la Pena F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F. Genetic testing for hereditary breast and ovarian cancer in the Murcian population using a comprehensive NGS panel. Fam Cancer. 2026 Mar 23;25(2):31. doi: 10.1007/s10689-026-00544-5. PubMed PMID: 41870673.
AÑO: 2026; IF: 2.0
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII